Liver Tumors

Chapter

Abstract

Primary malignant liver tumours are rare and account for 1–2% of all solid tumours in childhood.

Hepatoblastoma (HB) is a rare solid tumor in infancy and toddlers that accounts for approximately 55% of all malignant liver tumours. The incidence is approximately 1 case per 1,000,000 children. The description of morphological and histological differences between HB and hepatocellular carcinoma (HCC) was a major discovery under the aspects of treatment efficiency and outcome for the children. The observation of an increased HB incidence in children born before 28 weeks gestation (birth weight below 1500 g) compared to children born at term is difficult to explain. The exposure of endogenous metabolites, hormones, as well as exogenous toxic substances e.g. drugs could influence the tumour development of dividing hepatoblasts.

Keywords

Liver tumors Newborns Classification Staging Surgery Outcomes. 

References

  1. 1.
    Perilongo G, Shafford EA. Liver tumours. Eur J Cancer. 1999;35(6):953–8.CrossRefGoogle Scholar
  2. 2.
    Jaing TH, Hung IJ, Lin JN, Lien RI, Hsueh C, Lu CS. Hepatoblastoma in a child of extremely low birth weight. Am J Perinatol. 2002;19(3):149–53.CrossRefGoogle Scholar
  3. 3.
    Hadzic N, Finegold MJ. Liver neoplasia in children. Clin Liver Dis. 2011;15(2):443–62.CrossRefGoogle Scholar
  4. 4.
    Spector LG, Ji H, Ross JEA. Hepatoblastoma incidence and very low birth weight in the US, 1981–1999. Am J Epidemiol. 2003;157(11):S15.Google Scholar
  5. 5.
    Zimmermann A. Pediatric liver tumors and hepatic ontogenesis: Common and distinctive pathways. Med Pediatr Oncol. 2002;39(5):492–503.CrossRefGoogle Scholar
  6. 6.
    Hill DA, Swanson PE, Anderson K, et al. Desmoplastic nested spindle cell tumor of liver: report of four cases of a proposed new entity. Am J Surg Pathol. 2005;29(1):1–9.CrossRefGoogle Scholar
  7. 7.
    Gupta AA, Gerstle JT, Ng V, et al. Critical review of controversial issues in the management of advanced pediatric liver tumors. Pediatr Blood Cancer. 2011;56(7):1013–8.CrossRefGoogle Scholar
  8. 8.
    Wang JD, Chang TK, Chen HC, et al. Pediatric liver tumors: initial presentation, image finding and outcome. Pediatr Int. 2007;49(4):491–6.CrossRefGoogle Scholar
  9. 9.
    Thomas D, Pritchard J, Davidson R, McKiernan P, Grundy RG, de Goyet JD. Familial hepatoblastoma and APC gene mutations: renewed call for molecular research. Eur J Cancer. 2003;39(15):2200–4.CrossRefGoogle Scholar
  10. 10.
    Murray MJ, Nicholson JC. Alpha-fetoprotein. Arch Dis Child Educ Pract Ed. 2011;96(4):141–7.CrossRefGoogle Scholar
  11. 11.
    von Schweinitz D. Management of liver tumors in childhood. Semin Pediatr Surg. 2006;15(1):17–24.CrossRefGoogle Scholar
  12. 12.
    Al-Hussein HA, Graham EM, Tekes A, Huisman TA. Pre- and postnatal imaging of a congenital hepatoblastoma. Fetal Diagn Ther. 2011;30(2):157–9.CrossRefGoogle Scholar
  13. 13.
    Warmann SW, Schenk A, Schaefer JF et al. Computer-assisted surgery planning in children with complex liver tumors identifies variability of the classical Couinaud classification. J Pediatr Surg. 2016;51(11):1801–6. doi: 10.1016/j.jpedsurg.2016.05.018.CrossRefGoogle Scholar
  14. 14.
    Sironi S, Messa C, Cistaro A, et al. Recurrent hepatoblastoma in orthotopic transplanted liver: detection with FDG positron emission tomography. AJR Am J Roentgenol. 2004;182(5):1214–6.CrossRefGoogle Scholar
  15. 15.
    Meyers RL, Katzenstein HM, Malogolowkin MH. Predictive value of staging systems in hepatoblastoma. J Clin Oncol. 2007;25(6):737–8.CrossRefGoogle Scholar
  16. 16.
    Aronson DC, Schnater JM, Staalman CR, et al. Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol. 2005;23(6):1245–52.CrossRefGoogle Scholar
  17. 17.
    Roebuck DJ, Olsen O, Pariente D. Radiological staging in children with hepatoblastoma. Pediatr Radiol. 2006;36(3):176–82.CrossRefGoogle Scholar
  18. 18.
    Meyers RL, Rowland JR, Krailo M, Chen Z, Katzenstein HM, Malogolowkin MH. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2009;53(6):1016–22.CrossRefGoogle Scholar
  19. 19.
    von Schweinitz D. Identification of risk groups in hepatoblastoma—another step in optimising therapy. Eur J Cancer. 2000;36(11):1343–6.CrossRefGoogle Scholar
  20. 20.
    Brown J, Perilongo G, Shafford E, et al. Pretreatment prognostic factors for children with hepatoblastoma results from the International Society of Paediatric Oncology (SIOP) Study SIOPEL 1. Eur J Cancer. 2000;36(11):1418–25.CrossRefGoogle Scholar
  21. 21.
    von Schweinitz D, Kraus JA, Albrecht S, Koch A, Fuchs J, Pietsch T. Prognostic impact of molecular genetic alterations in hepatoblastoma. Med Pediatr Oncol. 2002;38(2):104–8.CrossRefGoogle Scholar
  22. 22.
    Yeh YA, Rao PH, Cigna CT, Middlesworth W, Lefkowitch JH, Murty VVVS. Trisomy 1q, 2, and 20 in a case of hepatoblastoma: Possible significance of 2q35-q37 and 1q12-q21 rearrangements. Cancer Genet Cytogenet. 2000;123(2):140–3.CrossRefGoogle Scholar
  23. 23.
    Taniguchi K, Roberts LR, Aderca IN, et al. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene. 2002;21(31):4863–71.CrossRefGoogle Scholar
  24. 24.
    Zerbini MCN, Sredni ST, Grier H, et al. Primary malignant epithelial tumors of the liver in children: A study of DNA content and oncogene expression. Pediatr Dev Pathol. 1998;1(4):270–80.CrossRefGoogle Scholar
  25. 25.
    Czauderna P, Haeberle B, Hiyama E, et al. The Children’s Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. Eur J Cancer. 2016;52:92–101.CrossRefGoogle Scholar
  26. 26.
    Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, Hishiki T, Schmid I, Watanabe K, Yoshimura K, Feng Y, Rinaldi E, Saraceno D, Derosa M, Czauderna P. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children’s Hepatic tumors International Collaboration. Lancet Oncol. 2017;18(1):122–131.CrossRefGoogle Scholar
  27. 27.
    Katzenstein HM, Rigsby C, Shaw PH, Mitchell TL, Haut PR, Kletzel M. Novel therapeutic approaches in the treatment of children with hepatoblastoma. J Pediatr Hematol Oncol. 2002;24(9):751–5.CrossRefGoogle Scholar
  28. 28.
    Perilongo G, Shafford E, Maibach R, et al. Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology—SIOPEL 2. Eur J Cancer. 2004;40(3):411–21.CrossRefGoogle Scholar
  29. 29.
    Haberle B, Bode U, von Schweinitz D. Differentiated treatment protocols for high- and standard-risk hepatoblastoma—An interim report of the German liver tumor study HB 99. Klin Padiatr. 2003;215(3):159–65.CrossRefGoogle Scholar
  30. 30.
    Malogolowkin MH, Katzenstein H, Krailo MD, et al. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. J Clin Oncol. 2006;24(18):2879–84.CrossRefGoogle Scholar
  31. 31.
    Perilongo G, Maibach R, Shafford E, et al. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med. 2009;361(17):1662–70.CrossRefGoogle Scholar
  32. 32.
    Zsiros J, Maibach R, Shafford E, et al. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. J Clin Oncol. 2010;28(15):2584–90.CrossRefGoogle Scholar
  33. 33.
    Katzenstein HM, Krailo MD, Malogolowkin MH, et al. Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer. 2003;97(8):2006–12.CrossRefGoogle Scholar
  34. 34.
    Schnater JM, Kuijper CF, Zsiros J, Heij HA, Aronson DC. Pre-operative diagnostic biopsy and surgery in paediatric liver tumours—the Amsterdam experience. Eur J Surg Oncol. 2005;31(10):1160–5.CrossRefGoogle Scholar
  35. 35.
    Fuchs J, Rydzynski J, von Schweinitz D, et al. Pretreatment prognostic factors and treatment results in children with hepatoblastoma—A report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer. 2002;95(1):172–82.CrossRefGoogle Scholar
  36. 36.
    Parikh B, Jojo A, Shah B, Bansal R, Trivedi P, Shah MJ. Fine needle aspiration cytology of hepatoblastoma: a study of 20 cases. Indian J Pathol Microbiol. 2005;48(3):331–6.Google Scholar
  37. 37.
    Czauderna P, Otte JB, Aronson DC, et al. Guidelines for surgical treatment of hepatoblastoma in the modern era—recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur J Cancer. 2005;41(7):1031–6.CrossRefGoogle Scholar
  38. 38.
    Fuchs J, Rydzynski J, Hecker H, et al. The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma—A report from the German Cooperative Liver Tumour Studies HB 89 and HB 94. Eur J Pediatr Surg. 2002;12(4):255–61.CrossRefGoogle Scholar
  39. 39.
    Schnater JM, Aronson DC, Plaschkes J, et al. Surgical view of the treatment of patients with hepatoblastoma—Results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group (SIOPEL-1). Cancer. 2002;94(4):1111–20.CrossRefGoogle Scholar
  40. 40.
    Pritchard J, Stringer M. Outcome and complications after resection of hepatoblastoma. J Pediatr Surg. 2004;39(11):1744–5.CrossRefGoogle Scholar
  41. 41.
    Szavay PO, Luithle T, Warmann SW, Geerlings H, Ure BM, Fuchs J. Impact of pedicle clamping in pediatric liver resection. Surg Oncol. 2008;17(1):17–22.CrossRefGoogle Scholar
  42. 42.
    Guerin F, Gauthier F, Martelli H, et al. Outcome of central hepatectomy for hepatoblastomas. J Pediatr Surg. 2010;45(3):555–63.CrossRefGoogle Scholar
  43. 43.
    Superina RA, Bambini D, Filler RM, Almond PS, Geissler G. A new technique for resecting ‘unresectable’ liver tumors. J Pediatr Surg. 2000;35(9):1294–9.CrossRefGoogle Scholar
  44. 44.
    Fuchs J, Cavdar S, Blumenstock G et al. POST-TEXT III and IV Hepatoblastoma: Extended hepatic resection avoids liver transplantation in selected cases. Ann Surg. 2017;266(2):318–23.CrossRefGoogle Scholar
  45. 45.
    Oldhafer KJ, Fuchs J, Steinhoff G, Mildenberger H. Extended liver resection in children under circulatory arrest and “low flow” cardiopulmonary bypass. Chirurg. 2000;71(6):692–5.CrossRefGoogle Scholar
  46. 46.
    Barrena S, Hernandez F, Miguel M, et al. High-risk hepatoblastoma: results in a pediatric liver transplantation center. Eur J Pediatr Surg. 2011;21(1):18–20.CrossRefGoogle Scholar
  47. 47.
    Stringer M, Pimpalwar A, Tovar J, Iyer Y, Tam P. Strategy for Hepatoblastoma management: Transplant versus nontransplant surgery—Discussion. J Pediatr Surg. 2002;37(2):245.Google Scholar
  48. 48.
    Otte JB, Meyers R. PLUTO first report. Pediatr Transplant. 2010;14(7):830–5.CrossRefGoogle Scholar
  49. 49.
    Perilongo G, Brown J, Shafford E, et al. Hepatoblastoma presenting with lung metastases—Treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on Childhood Liver Tumors. Cancer. 2000;89(8):1845–53.CrossRefGoogle Scholar
  50. 50.
    Urla C, Seitz G, Tsiflikas I, et al. Simultaneous Resection of High-risk Liver Tumors and Pulmonary Metastases in Children. Ann Surg. 2015;262(1):e1–3.CrossRefGoogle Scholar
  51. 51.
    Otte JB, de Ville DG, Reding R. Liver transplantation for hepatoblastoma: indications and contraindications in the modern era. Pediatr Transplant. 2005;9(5):557–65.CrossRefGoogle Scholar
  52. 52.
    Otte JB. de Ville dG. The contribution of transplantation to the treatment of liver tumors in children. Semin Pediatr Surg. 2005;14(4):233–8.CrossRefGoogle Scholar
  53. 53.
    Czauderna P, Zbrzezniak G, Narozanski W, Korzon M, Wyszomirska M, Stoba C. Preliminary experience with arterial chemoembolization for hepatoblastoma and hepatocellular carcinoma in children. Pediatr Blood Cancer. 2006;46(7):825–8.CrossRefGoogle Scholar
  54. 54.
    Malogolowkin MH, Stanley P, Steele DA, Ortega JA. Feasibility and toxicity of chemoembolization for children with liver tumors. J Clin Oncol. 2000;18(6):1279–84.CrossRefGoogle Scholar
  55. 55.
    Tashjian DB, Moriarty KP, Courtney RA, Bean MS, Steele DA. Preoperative chemoembolization for unresectable hepatoblastoma. Pediatr Surg Int. 2002;18(2–3):187–9.CrossRefGoogle Scholar
  56. 56.
    Goering JD, Mahvi DM, Niederhuber JE, Chicks D, Rikkers LF. Cryoablation and liver resection for noncolorectal liver metastases. Am J Surg. 2002;183(4):384–9.CrossRefGoogle Scholar
  57. 57.
    Schnater JM, Kohler SE, Lamers WH, von Schweinitz D, Aronson DC. Where do we stand with hepatoblastoma? Cancer. 2003;98(4):668–78.CrossRefGoogle Scholar
  58. 58.
    Sasaki F, Matsunaga T, Iwafuchi M, et al. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor. J Pediatr Surg. 2002;37(6):851–6.CrossRefGoogle Scholar
  59. 59.
    Stringer MD. The role of liver transplantation in the management of paediatric liver tumours. Ann R Coll Surg Engl. 2007;89(1):12–21.CrossRefGoogle Scholar
  60. 60.
    Otte JB, Pritchard J, Aronson DC, et al. Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer. 2004;42(1):74–83.CrossRefGoogle Scholar
  61. 61.
    Katzenstein HM, Krailo MD, Malogolowkin MH, et al. Hepatocellular carcinoma in children and adolescents: Results from the Pediatric Oncology Group and the Children’s Cancer Group intergroup study. J Clin Oncol. 2002;20(12):2789–97.CrossRefGoogle Scholar
  62. 62.
    Czauderna P. Adult type vs. childhood hepatocellular carcinoma—Are they the same or different lesions? Biology, natural history, prognosis, and treatment. Med Pediatr Oncol. 2002;39(5):519–23.CrossRefGoogle Scholar
  63. 63.
    Hutten M, Lassay L, Sachs B, et al. Successful topical treatment of sorafenib-induced hand-foot skin reaction in a child with hepatocellular carcinoma. Pediatr Dermatol. 2009;26(3):349–50.CrossRefGoogle Scholar
  64. 64.
    Leuschner I, Schmidt D, Harms D. Undifferentiated sarcoma of the liver in childhood: morphology, flow cytometry, and literature review. Hum Pathol. 1990;21(1):68–76.CrossRefGoogle Scholar
  65. 65.
    Lack EE, Schloo BL, Azumi N, Travis WD, Grier HE, Kozakewich HP. Undifferentiated (embryonal) sarcoma of the liver. Clinical and pathologic study of 16 cases with emphasis on immunohistochemical features. Am J Surg Pathol. 1991;15(1):1–16.CrossRefGoogle Scholar
  66. 66.
    Shehata BM, Gupta NA, Katzenstein HM, et al. Undifferentiated embryonal sarcoma of the liver is associated with mesenchymal hamartoma and multiple chromosomal abnormalities: a review of eleven cases. Pediatr Dev Pathol. 2011;14(2):111–6.CrossRefGoogle Scholar
  67. 67.
    Moon WK, Kim WS, Kim IO, et al. Undifferentiated embryonal sarcoma of the liver: US and CT findings. Pediatr Radiol. 1994;24(7):500–3.CrossRefGoogle Scholar
  68. 68.
    Geramizadeh B, Safari A, Bahador A, et al. Hepatic angiosarcoma of childhood: a case report and review of literature. J Pediatr Surg. 2011;46(1):e9–11.CrossRefGoogle Scholar
  69. 69.
    Jayaram A, Finegold MJ, Parham DM, Jasty R. Successful management of rhabdoid tumor of the liver. J Pediatr Hematol Oncol. 2007;29(6):406–8.CrossRefGoogle Scholar
  70. 70.
    Szavay PO, Wermes C, Fuchs J, Schrappe M, Flemming P, Von SD. Effective treatment of infantile choriocarcinoma in the liver with chemotherapy and surgical resection: a case report. J Pediatr Surg. 2000;35(7):1134–5.CrossRefGoogle Scholar
  71. 71.
    Hanson D, Walter AW, Dunn S, Rittenhouse DW, Griffin G. Infantile choriocarcinoma in a neonate with massive liver involvement cured with chemotherapy and liver transplant. J Pediatr Hematol Oncol. 2011;33(6):e258–60.CrossRefGoogle Scholar
  72. 72.
    Weinberg AG, Finegold MJ. Primary hepatic tumors of childhood. Hum Pathol. 1983;14(6):512–37.CrossRefGoogle Scholar
  73. 73.
    Sato M, Ishida H, Konno K, et al. Liver tumors in children and young patients: sonographic and color Doppler findings. Abdom Imaging. 2000;25(6):596–601.CrossRefGoogle Scholar
  74. 74.
    Horii KA, Drolet BA, Frieden IJ, et al. Prospective study of the frequency of hepatic hemangiomas in infants with multiple cutaneous infantile hemangiomas. Pediatr Dermatol. 2011;28(3):245–53.CrossRefGoogle Scholar
  75. 75.
    Szymik-Kantorowicz S, Kobylarz K, Krysta M, et al. Interferon-alpha in the treatment of high-risk haemangiomas in infants. Eur J Pediatr Surg. 2005;15(1):11–6.CrossRefGoogle Scholar
  76. 76.
    Warmann S, Bertram H, Kardorff R, Sasse M, Hausdorf G, Fuchs J. Interventional treatment of infantile hepatic hemangioendothelioma. J Pediatr Surg. 2003;38(8):1177–81.CrossRefGoogle Scholar
  77. 77.
    von Schweinitz D. Neonatal liver tumours. Semin Neonatol. 2003;8(5):403–10.CrossRefGoogle Scholar
  78. 78.
    Stringer MD, Alizai NK. Mesenchymal hamartoma of the liver: a systematic review. J Pediatr Surg. 2005;40(11):1681–90.CrossRefGoogle Scholar
  79. 79.
    Fuchs J, Schweinitz DV, Feickert HJ. Acute respiratory distress syndrome following resection of a mesenchymal hamartoma of the liver. Med Pediatr Oncol. 1999;32(2):151–3.CrossRefGoogle Scholar
  80. 80.
    Takayasu H, Motoi T, Kanamori Y, et al. Two case reports of childhood liver cell adenomas harboring beta-catenin abnormalities. Hum Pathol. 2002;33(8):852–5.CrossRefGoogle Scholar
  81. 81.
    Bouyn CI, Leclere J, Raimondo G, et al. Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome. Cancer. 2003;97(12):3107–13.CrossRefGoogle Scholar
  82. 82.
    Towbin AJ, Luo GG, Yin H, Mo JQ. Focal nodular hyperplasia in children, adolescents, and young adults. Pediatr Radiol. 2011;41(3):341–9.CrossRefGoogle Scholar
  83. 83.
    Gutweiler JR, Yu DC, Kim HB, et al. Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma. J Pediatr Surg. 2008;43(12):2297–300.CrossRefGoogle Scholar
  84. 84.
    Lautz T, Tantemsapya N, Dzakovic A, Superina R. Focal nodular hyperplasia in children: clinical features and current management practice. J Pediatr Surg. 2010;45(9):1797–803.CrossRefGoogle Scholar
  85. 85.
    Reymond D, Plaschkes J, Luthy AR, Leibundgut K, Hirt A, Wagner HP. Focal nodular hyperplasia of the liver in children: review of follow-up and outcome. J Pediatr Surg. 1995;30(11):1590–3.CrossRefGoogle Scholar
  86. 86.
    Czauderna P, Mackinley G, Perilongo G, et al. Hepatocellular carcinoma in children: results of the first prospective study of the Internantional Society of Pediatric Oncology group. J Clin Oncol. 2002;20(12):2798–804.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Ltd., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Pediatric Surgery and Pediatric UrologyUniversity Children’s Hospital, University of TuebingenTuebingenGermany

Personalised recommendations